A purified form of CBD, one compound found in marijuana, is an FDA-approved treatment for certain severe forms of epilepsy. But that’s a narrower answer than most people expect. Smoking or eating marijuana itself has not been proven effective for seizure control, and the psychoactive component THC lacks the clinical evidence that CBD now has. The distinction between pharmaceutical-grade CBD and the marijuana you’d buy at a dispensary matters enormously here.
What the FDA Has Actually Approved
The only cannabis-derived medication approved by the FDA for epilepsy is a prescription oral solution of purified cannabidiol (CBD). It is approved to treat seizures in three specific, severe epilepsy syndromes: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. All three are rare, difficult-to-treat conditions that often begin in childhood, and patients with these syndromes frequently don’t respond well to conventional seizure medications.
This approval matters because it came through the same rigorous clinical trial process as any other prescription drug. The CBD in this medication is a single, isolated compound produced at a precise concentration, which is fundamentally different from whole-plant marijuana that contains hundreds of compounds in unpredictable ratios.
How Well Purified CBD Works
The clinical trial results are meaningful, though not miraculous. In a randomized trial of 120 children and adolescents with Dravet syndrome, monthly convulsive seizures dropped from a median of 12.4 to 5.9 in the CBD group, a 39% reduction. The placebo group saw only a 13% reduction. About 43% of patients on CBD experienced at least a 50% drop in convulsive seizures, compared to 27% on placebo.
For Lennox-Gastaut syndrome, the results were even stronger over time. In a real-world UK study, patients saw a roughly 57% reduction in motor seizures at six months and a 60% reduction at twelve months. Two-thirds of patients achieved at least a 50% reduction in seizures by the one-year mark, and 40% hit a 75% or greater reduction.
Patients with tuberous sclerosis complex showed sustained benefits over long-term treatment. In an open-label extension trial lasting up to 144 weeks (nearly three years), focal seizures decreased by 54% to 88% depending on the time interval measured. More than half of patients maintained at least a 50% reduction in focal seizures throughout the study period.
Real-world data on long-term use shows significant reductions in drop seizures ranging from 48% to 71%. These numbers represent patients who had already failed multiple other medications, which makes the improvements more impressive.
How CBD Reduces Seizures
CBD appears to calm overexcited nerve cells through several pathways at once. It blocks a receptor on nerve cells that normally promotes calcium release inside the cell. Since calcium surges drive the electrical chain reactions behind seizures, dampening that signal reduces seizure activity. CBD also desensitizes a separate channel that lets calcium flow into nerve cells from outside, further quieting excessive nerve signaling. A third pathway involves boosting a natural calming molecule your body already produces. This multi-target approach may explain why CBD helps some patients who haven’t responded to drugs that work through a single mechanism.
Whole-Plant Marijuana Is a Different Story
Here’s where things get complicated for people hoping their local dispensary holds the answer. The marijuana plant contains over 100 different cannabinoids, with THC and CBD being the most abundant. THC is the compound that produces the “high,” and its effects on seizures are far less clear than CBD’s. Some preclinical research suggests THC could lower the seizure threshold in certain circumstances, potentially making seizures more likely rather than less. The scientific evidence for using whole-plant marijuana or THC-dominant products to treat epilepsy simply doesn’t exist at the level it does for purified CBD.
Dispensary products also pose a consistency problem. The CBD-to-THC ratio, the total cannabinoid content, and the presence of other plant compounds vary widely between products and even between batches of the same product. For a condition where precise, consistent dosing matters, this unpredictability is a real liability. The prescription form is dosed by body weight, starting at 5 mg/kg per day and potentially increasing to a maximum of 20 mg/kg per day in careful weekly steps. That level of precision isn’t possible with unregulated products.
Side Effects to Know About
Pharmaceutical CBD is generally well tolerated, but it isn’t side-effect free. The most common issues include drowsiness, decreased appetite, diarrhea, and fatigue. Some patients experience nausea or vomiting. Liver enzyme elevations can occur, which is why doctors monitor liver function through blood tests during treatment. Signs of liver problems include dark urine, yellowing of the skin or eyes, and pain in the upper stomach area.
One particularly important consideration is how CBD interacts with other seizure medications. CBD is processed by the same liver enzymes that break down several common anti-epileptic drugs. When taken together, CBD can slow the metabolism of these other medications, effectively raising their levels in the body. This is especially relevant for one widely used seizure drug, clobazam, whose active form can build up and cause increased sedation. Doctors typically need to adjust doses of other medications when adding CBD to the mix, which is another reason this isn’t something to try on your own with over-the-counter products.
Where Epilepsy Organizations Stand
The American Epilepsy Society supports well-controlled research into cannabis-based treatments and has publicly backed rescheduling marijuana from Schedule I to Schedule III to make rigorous clinical research easier. Their position is pragmatic: the evidence for purified CBD in specific epilepsy syndromes is strong, but much more research is needed to understand whether other cannabis compounds or formulations have therapeutic value. They stop short of endorsing dispensary marijuana as a seizure treatment.
This distinction, between supporting research and recommending use, reflects where the science actually stands. Purified CBD has earned its place as a legitimate epilepsy medication for specific syndromes. Marijuana as a whole plant, bought recreationally or from a medical dispensary, has not cleared that bar. If you or someone you care about has epilepsy that isn’t well controlled, the conversation worth having is with a neurologist about whether pharmaceutical-grade CBD is appropriate for the specific type of epilepsy involved.